Effectiveness of myringoplasty in patients with eosinophilic otitis media.


Journal

Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 10 06 2020
revised: 28 08 2020
accepted: 11 09 2020
pubmed: 1 10 2020
medline: 11 11 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

To determine whether myringoplasty can be an effective tool to control eosinophilic otitis media and improve hearing. Severity scores for patients with eosinophilic otitis media with or without myringoplasty were retrospectively analyzed. Surgical outcomes were assessed and compared to those of patients with control: chronic otitis media with tympanic membrane perforation. The average eosinophilic otitis media severity score for the patients with myringoplasty was significantly lower after than before surgery (P = 0.004), although the score for the group without myringoplasty remained stable during the study period. The success rate for graft uptake was 87.5%, and a statistically significant improvement was observed in the postoperative air conduction hearing level within the speech range (mean ± standard deviation; 41.5 ± 12.3 to 34.6 ± 9.22 dB; P = 0.0026) for patients with eosinophilic otitis media. Myringoplasty contributed to decreased postoperative eosinophilic otitis media severity scores and should be considered to protect the patients from recurrent bacterial infections and pathogenic antigen parasitism in the middle ear.

Identifiants

pubmed: 32994077
pii: S0385-8146(20)30252-2
doi: 10.1016/j.anl.2020.09.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-376

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Yoshihiko Esu (Y)

Jichi Ika University Saitama Medical Center, Department of Otolaryngology, 1-847 Amanuma, Saitama 330-8503, Japan. Electronic address: yesu@jichi.ac.jp.

Satoru Tamii (S)

Jichi Ika University Saitama Medical Center, Department of Otolaryngology, 1-847 Amanuma, Saitama 330-8503, Japan.

Maria Masuda (M)

Jichi Ika University Saitama Medical Center, Department of Otolaryngology, 1-847 Amanuma, Saitama 330-8503, Japan.

Yukiko Iino (Y)

Tokyo-Kita Medical Center, Department of Otolaryngology, Tokyo, Japan.

Naohiro Yoshida (N)

Jichi Ika University Saitama Medical Center, Department of Otolaryngology, 1-847 Amanuma, Saitama 330-8503, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH